Expression of the Bax inhibitor‐1 gene in pulmonary adenocarcinoma
Authors:
- Tadashi IshiyamaTITadashi Ishiyama
- Masayuki NoguchiMNMasayuki Noguchi
Open Access
Abstract
BACKGROUND: The regulation of programmed cell death, or apoptosis, is crucial for normal development and for the maintenance of homeostasis. It has been shown that the novel antiapoptotic protein Bax inhibitor‐1 (BI‐1) represents a new type of regulator of cell death pathways controlled by Bcl‐2 and Bax.METHODS: Surgically resected lung specimens were obtained from 32 patients with peripheral adenocarcinomas, and BI‐1 gene expression was examined and compared with expression of the p53, bcl‐2 and Bax genes.RESULTS: Fourteen of 32 tumors (43.8%) were positive for BI‐1 gene expression by in situ hybridization. BI‐1 gene expression in tumor specimens was significantly higher in adenocarcinomas with bronchioloalveolar carcinoma (BAC) and in adenocarcinomas of mixed subtypes with bronchioloalveolar spreading (14 of 17 tumors; 82.4%) than in carcinomas without it spreading. Patients who had BI‐1‐positive adenocarcinoma showed a relatively favorable prognosis compared with patients who had BI‐1‐negative adenocarcinoma. Eleven of 32 tumors (34.4%) were positive for the p53 protein, only 1 of 32 tumors (3.1%) was positive for the Bcl‐2 protein, and 26 of 32 tumors (81.3%) were positive for the Bax protein. Protein expressions of p53, Bcl‐2, and Bax, as detected by immunohistochemistry, were not associated with BI‐1 gene expression.CONCLUSIONS: BI‐1 gene expression was restricted to tumor cells with lepidic growth and was a prognostic factor for peripheral‐type adenocarcinoma. It is believed that BI‐1 gene expression is conserved evolutionarily and may act as a key regulator of the apoptotic pathway in BAC. Cancer 2006. © 2005 American Cancer Society.Keywords
This publication has 9 references indexed in Scilit:
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomasInternational Journal of Cancer, 2001
- The Bax Inhibitor-1 Gene Is Differentially Regulated in Adult Testis and Developing Lung by Two Alternative TATA-less PromotersGenomics, 1999
- Histological Typing of Lung and Pleural Tumours1999
- Bax Inhibitor-1, a Mammalian Apoptosis Suppressor Identified by Functional Screening in YeastMolecular Cell, 1998
- Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: Analysis of 427 casesHuman Pathology, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Small adenocarcinoma of the lung. Histologic characteristics and prognosisCancer, 1995
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993